Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Pirtobrutinib bulk supplier for pharma manufacturers

Pirtobrutinib 50mg, 100mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 50mg, 100mg

Reference Brands: Jaypirca(USA/EU)

Category: Oncology Cancer Care

Pirtobrutinib is a highly selective, non-covalent BTK inhibitor designed to overcome resistance to earlier BTK inhibitors. It is used in the treatment of chronic lymphocytic leukemia, small lymphocytic lymphoma, and mantle cell lymphoma. By reversibly inhibiting BTK, it blocks signaling required for cancer cell survival and proliferation.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

📘 Sourcing Guide

Pirtobrutinib — third party manufacturing & bulk supply

Pirtobrutinib 50mg, 100mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

What to include when you enquire

  • Destination market — determines which manufacturers hold the right site-level approvals
  • First order quantity and estimated annual volume
  • Whether you need a registration dossier or the product is already registered
  • Packaging, labelling and language requirements
  • Incoterms and required shelf life

Manufacturers of Pirtobrutinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.

Request a quote for Pirtobrutinib →
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'

The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing

Frequently Asked Questions

Pirtobrutinib is used for the treatment of relapsed or refractory mantle cell lymphoma (MCL) and certain previously treated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL). It helps inhibit cancer cell growth by targeting the BTK pathway.

Pirtobrutinib is made from a highly selective, non-covalent (reversible) Bruton’s tyrosine kinase (BTK) inhibitor designed to target both wild-type and resistant BTK mutations.

The trade name is Jaypirca.

Jaypirca is manufactured by Eli Lilly and Company.

The generic name is Pirtobrutinib.

The brand name is Jaypirca.

It is manufactured by Eli Lilly in its regulated production facilities in the United States and other global sites for international supply.

Related Products

Fruquin 5 Mg (Fruquintinib)

Strength:
5 Mg

Form: Capsules

Reference Brands: Everest Bangladesh altd.

View Details
Vorinostat

Strength:
100 mg

Form: Capsules

Reference Brands: Zolinza (USA/EU), Vornat (India)

View Details
Panobinostat Lactate

Strength:
10 mg, 15 mg, 20 mg

Form: Capsules

Reference Brands: Farydak (USA/EU),

View Details
Gilteritinib

Strength:
40 mg

Form: Tablets

Reference Brands: Xospata (USA/India), LuciGil (Asia)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.